2019 Intravenous Immunoglobulin (IVIg) Industry Report by Major Key Players Depth Research

Press Release

“Global Intravenous Immunoglobulin (IVIg) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024” includes various market segments such as market share, size, growth, trends, revenue and forecast by company profiles, products / types, applications / end-users and worldwide regional analysis with SWOT analysis and landscape and industrial competition overview of Intravenous Immunoglobulin (IVIg) Market.

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Scope of the Report:

North America region is the largest supplier of intravenous immunoglobulin (IVIg), with a production market share nearly 48% in 2016. Europe is the second largest supplier of intravenous immunoglobulin (IVIg), enjoying production market share nearly 23% in 2016.

North America is the largest sales place, with a sales market share nearly 44% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 22%.

Market competition is intense. Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for Intravenous Immunoglobulin (IVIg) is expected to grow at a CAGR of roughly 6.0% over the next five years, will reach 11500 million US$ in 2024, from 8120 million US$ in 2019.

This report focuses on the Intravenous Immunoglobulin (IVIg) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Browse full table of contents and data tables at


The Intravenous Immunoglobulin (IVIg) Market will reach Million USD in 2019. The report begins from overview of market size and forecast by types, regions and applications, also, this report introduces market competitive analysis among the companies and company profile, besides, market price analysis and value chain features are covered in this report.

Market Segment by Manufacturers, this report covers (Sales Revenue, Price, Gross Margin, Main Products etc.):

  • Baxter
  • Grifols
  • CSL
  • Octapharma
  • Biotest
  • Kedrion
  • Hualan Bio
  • CNBG
  • Shanghai RAAS
  • CBPO
  • LFB Group
  • BPL
  • Sichuan Yuanda Shuyang

Market Segment by Type, covers (Market Size & Forecast, Major Vendors of Type etc.):

  • IVIg Liquid
  • IVIg Powder

Get a sample of this [email protected]


Market Segment by Applications, can be divided into (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

  • Immunodeficiency
  • Autoimmune Disease
  • Acute Infection

Market Segment by Regions, regional analysis covers:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia etc.)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Get a Purchase Copy [email protected]


The content of the study subjects, includes a total of 15 chapters:

  1. Chapter 1, to describe Intravenous Immunoglobulin (IVIg) product scope, market overview, market opportunities, market driving force and market risks.
  2. Chapter 2, to profile the top manufacturers of Intravenous Immunoglobulin (IVIg), with price, sales, revenue and global market share of Intravenous Immunoglobulin (IVIg) in 2017 and 2018.
  3. Chapter 3, the Intravenous Immunoglobulin (IVIg) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
  4. Chapter 4, the Intravenous Immunoglobulin (IVIg) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
  5. Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
  6. Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
  7. Chapter 12, Intravenous Immunoglobulin (IVIg) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
  8. Chapter 13, 14 and 15, to describe Intravenous Immunoglobulin (IVIg) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Ask For a Discount on This Report @


About Us: MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on World industries, organizations, products, and trends.

Contact Us: Mr. Jeet Jain, Sales Manager, [email protected] ;

+1-240-284-8070, +44-20-3290-4151;

         Connect with us:  Google+ | LinkedIn | Twitter | Facebook